NDC 63102-101

ACTINEL

Dextromethorphan Hbr,guaifenesin,pseudoephedrine Hcl

ACTINEL is a Oral Solution in the Human Otc Drug category. It is labeled and distributed by Actipharma, Inc. The primary component is Dextromethorphan Hydrobromide; Guaifenesin; Pseudoephedrine Hydrochloride.

Product ID63102-101_b8c3cfe5-6c95-4598-8732-110eab8daf66
NDC63102-101
Product TypeHuman Otc Drug
Proprietary NameACTINEL
Generic NameDextromethorphan Hbr,guaifenesin,pseudoephedrine Hcl
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2014-09-24
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameActipharma, Inc
Substance NameDEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength15 mg/5mL; mg/5mL; mg/5mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 63102-101-16

474 mL in 1 BOTTLE (63102-101-16)
Marketing Start Date2014-09-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63102-101-16 [63102010116]

ACTINEL SOLUTION
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2014-09-24

Drug Details

Active Ingredients

IngredientStrength
DEXTROMETHORPHAN HYDROBROMIDE15 mg/5mL

OpenFDA Data

SPL SET ID:db0cb6ae-0a4d-4232-805a-f3f3a058261f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1098227
  • NDC Crossover Matching brand name "ACTINEL" or generic name "Dextromethorphan Hbr,guaifenesin,pseudoephedrine Hcl"

    NDCBrand NameGeneric Name
    63102-101ACTINELDextromethorphan HBr,Guaifenesin,Pseudoephedrine HCl
    63102-102ACTINEL PEDIATRICDextromethorphan HBr,Guaifenesin,Pseudoephedrine HCl

    Trademark Results [ACTINEL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ACTINEL
    ACTINEL
    74603219 not registered Dead/Abandoned
    Procter & Gamble Company, The
    1994-11-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.